Similar articles

• Pharmaceuticals and medical devices: FDA oversight. Issue brief.

  Berry MD. Berry MD. Issue Brief Health Policy Track Serv. 2012 Dec 31:1-79. Issue Brief Health Policy Track Serv. 2012. PMID: 23297449 No abstract available.
• Pharmaceuticals and medical devices: FDA oversight. Issue brief.

  Thomson Reuters/West. Thomson Reuters/West. Issue Brief Health Policy Track Serv. 2011 Jan 3:1-39. Issue Brief Health Policy Track Serv. 2011. PMID: 21374841 No abstract available.
• Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.

  Chaps NA. Chaps NA. Issue Brief Health Policy Track Serv. 2010 Jan 4:1-31. Issue Brief Health Policy Track Serv. 2010. PMID: 20217914 No abstract available.
• Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny.

  Strawn MN. Strawn MN. J Contemp Health Law Policy. 2003 Spring;19(2):495-520. J Contemp Health Law Policy. 2003. PMID: 14748255 Review. No abstract available.
• Ashes to ashes: why FDA regulation of tobacco advertising may mark the end of the road for the Marlboro man.

  Paralusz KM. Paralusz KM. Am J Law Med. 1998;24(1):89-122. Am J Law Med. 1998. PMID: 9607105 Review. No abstract available.